Cargando…

Metabolic phenotype in Darier disease: a cross-sectional clinical study

BACKGROUND: Human data supporting a role for endoplasmic reticulum (ER) stress and calcium dyshomeostasis in diabetes is scarce. Darier disease (DD) is a hereditary skin disease caused by mutations in the ATP2A2 gene encoding the sarcoendoplasmic-reticulum ATPase 2 (SERCA2) calcium pump, which cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahanian, Tara, Curman, Philip, Leong, Ivone U. S., Brismar, Kerstin, Bachar-Wikstrom, Etty, Cederlöf, Martin, Wikstrom, Jakob D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003329/
https://www.ncbi.nlm.nih.gov/pubmed/32042314
http://dx.doi.org/10.1186/s13098-020-0520-0
_version_ 1783494510743912448
author Ahanian, Tara
Curman, Philip
Leong, Ivone U. S.
Brismar, Kerstin
Bachar-Wikstrom, Etty
Cederlöf, Martin
Wikstrom, Jakob D.
author_facet Ahanian, Tara
Curman, Philip
Leong, Ivone U. S.
Brismar, Kerstin
Bachar-Wikstrom, Etty
Cederlöf, Martin
Wikstrom, Jakob D.
author_sort Ahanian, Tara
collection PubMed
description BACKGROUND: Human data supporting a role for endoplasmic reticulum (ER) stress and calcium dyshomeostasis in diabetes is scarce. Darier disease (DD) is a hereditary skin disease caused by mutations in the ATP2A2 gene encoding the sarcoendoplasmic-reticulum ATPase 2 (SERCA2) calcium pump, which causes calcium dyshomeostasis and ER stress. We hypothesize that DD patients have a diabetes-like metabolic phenotype and the objective of this study was to examine the association between DD with impaired glucose tolerance and diabetes. METHODS: Cross-sectional clinical study on 25 DD patients and 25 matched controls. Metabolic status was assessed primarily by fasting blood glucose, oral glucose tolerance test, HOMA2-%S (insulin resistence) and HOMA2-%B (beta cell function). RESULTS: DD subjects showed normal oral glucose tolerance test and HOMA2-%S, while fasting blood glucose was lower and c-peptide as well as HOMA2-%B was higher. CONCLUSION: Increased HOMA2-%B values are indicative of increased basal insulin secretion which is a type of beta cell dysfunction associated to diabetes development. These results supports a role of ER stress in diabetes pathophysiology and contribute to the understanding of DD as a multi-organ syndrome.
format Online
Article
Text
id pubmed-7003329
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70033292020-02-10 Metabolic phenotype in Darier disease: a cross-sectional clinical study Ahanian, Tara Curman, Philip Leong, Ivone U. S. Brismar, Kerstin Bachar-Wikstrom, Etty Cederlöf, Martin Wikstrom, Jakob D. Diabetol Metab Syndr Research BACKGROUND: Human data supporting a role for endoplasmic reticulum (ER) stress and calcium dyshomeostasis in diabetes is scarce. Darier disease (DD) is a hereditary skin disease caused by mutations in the ATP2A2 gene encoding the sarcoendoplasmic-reticulum ATPase 2 (SERCA2) calcium pump, which causes calcium dyshomeostasis and ER stress. We hypothesize that DD patients have a diabetes-like metabolic phenotype and the objective of this study was to examine the association between DD with impaired glucose tolerance and diabetes. METHODS: Cross-sectional clinical study on 25 DD patients and 25 matched controls. Metabolic status was assessed primarily by fasting blood glucose, oral glucose tolerance test, HOMA2-%S (insulin resistence) and HOMA2-%B (beta cell function). RESULTS: DD subjects showed normal oral glucose tolerance test and HOMA2-%S, while fasting blood glucose was lower and c-peptide as well as HOMA2-%B was higher. CONCLUSION: Increased HOMA2-%B values are indicative of increased basal insulin secretion which is a type of beta cell dysfunction associated to diabetes development. These results supports a role of ER stress in diabetes pathophysiology and contribute to the understanding of DD as a multi-organ syndrome. BioMed Central 2020-02-05 /pmc/articles/PMC7003329/ /pubmed/32042314 http://dx.doi.org/10.1186/s13098-020-0520-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ahanian, Tara
Curman, Philip
Leong, Ivone U. S.
Brismar, Kerstin
Bachar-Wikstrom, Etty
Cederlöf, Martin
Wikstrom, Jakob D.
Metabolic phenotype in Darier disease: a cross-sectional clinical study
title Metabolic phenotype in Darier disease: a cross-sectional clinical study
title_full Metabolic phenotype in Darier disease: a cross-sectional clinical study
title_fullStr Metabolic phenotype in Darier disease: a cross-sectional clinical study
title_full_unstemmed Metabolic phenotype in Darier disease: a cross-sectional clinical study
title_short Metabolic phenotype in Darier disease: a cross-sectional clinical study
title_sort metabolic phenotype in darier disease: a cross-sectional clinical study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003329/
https://www.ncbi.nlm.nih.gov/pubmed/32042314
http://dx.doi.org/10.1186/s13098-020-0520-0
work_keys_str_mv AT ahaniantara metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy
AT curmanphilip metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy
AT leongivoneus metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy
AT brismarkerstin metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy
AT bacharwikstrometty metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy
AT cederlofmartin metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy
AT wikstromjakobd metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy